NASDAQ:CRONCronos Group Stock Price, Forecast & News

Cronos Group's stock was trading at $5.41 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, CRON stock has increased by 23.8% and is now trading at $6.70. View which stocks have been most impacted by Coronavirus.

11 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last year. There are currently 1 sell rating, 7 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for Cronos Group.

Cronos Group is scheduled to release its next quarterly earnings announcement on Thursday, August 13th 2020. View our earnings forecast for Cronos Group.

Cronos Group Inc (NASDAQ:CRON) issued its quarterly earnings results on Friday, May, 8th. The company reported $0.20 earnings per share (EPS) for the quarter, topping the Thomson Reuters' consensus estimate of ($0.07) by $0.27. The business earned $8.40 million during the quarter, compared to analyst estimates of $13.05 million. Cronos Group had a net margin of 2,705.97% and a return on equity of 0.72%. Cronos Group's quarterly revenue was up 29.2% compared to the same quarter last year. During the same period last year, the company earned $0.48 EPS. View Cronos Group's earnings history.

11 analysts have issued twelve-month price objectives for Cronos Group's stock. Their forecasts range from $6.50 to $17.00. On average, they anticipate Cronos Group's share price to reach $9.44 in the next year. This suggests a possible upside of 41.0% from the stock's current price. View analysts' price targets for Cronos Group.

Media stories about CRON stock have trended very negative recently, according to InfoTrie Sentiment Analysis. The research group identifies positive and negative press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores nearest to five being the most favorable. Cronos Group earned a daily sentiment score of -3.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutCronos Group.

Cronos Group saw a drop in short interest during the month of April. As of April 30th, there was short interest totaling 42,590,000 shares, a drop of 11.4% from the April 15th total of 48,060,000 shares. Based on an average daily trading volume, of 6,500,000 shares, the short-interest ratio is presently 6.6 days. Approximately 23.5% of the shares of the company are sold short. View Cronos Group's Current Options Chain.

Some companies that are related to Cronos Group include Canopy Growth (CGC), STADA Arzneimittel (STDAF), USANA Health Sciences (USNA), Aurora Cannabis (ACB), Tilray (TLRY), Aphria (APHA), Canopy Rivers (RIV), Chromadex (CDXC), Sundial Growers (SNDL), Happiness Biotech Group (HAPP), Mediwound (MDWD), Natural Alternatives International (NAII), Mannatech (MTEX), Cyanotech (CYAN) and True Drinks (TRUU). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Tilray (TLRY), Aphria (APHA), NVIDIA (NVDA), Dollar Tree (DLTR), Advanced Micro Devices (AMD), Micron Technology (MU), Alibaba Group (BABA) and OrganiGram (OGI).

Cronos Group trades on the NASDAQ under the ticker symbol "CRON."

Cronos Group's stock is owned by a variety of institutional and retail investors. Top institutional investors include ETF Managers Group LLC (2.24%), Morgan Stanley (0.38%), Swiss National Bank (0.21%), Legal & General Group Plc (0.19%), Public Sector Pension Investment Board (0.16%) and Polar Asset Management Partners Inc. (0.14%).

CRON stock was sold by a variety of institutional investors in the last quarter, including Polar Asset Management Partners Inc., Morgan Stanley, Wedbush Securities Inc., Janney Montgomery Scott LLC, Cambridge Investment Research Advisors Inc., Janus Henderson Group PLC, HighTower Advisors LLC, and AE Wealth Management LLC.

CRON stock was purchased by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Legal & General Group Plc, Valinor Management L.P., Nomura Holdings Inc., Geode Capital Management LLC, ETF Managers Group LLC, Swiss National Bank, and APG Asset Management N.V..

Shares of CRON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of CRON stock can currently be purchased for approximately $6.70.

Cronos Group has a market capitalization of $2.34 billion and generates $25.64 million in revenue each year. The company earns $1.17 billion in net income (profit) each year or $0.67 on an earnings per share basis. Cronos Group employs 291 workers across the globe.

The official website for Cronos Group is www.thecronosgroup.com.

Cronos Group's mailing address is 720 KING STREET W SUITE 320, TORONTO A6, M5V 2T3. The company can be reached via phone at 416-504-0004.